Navigation Links
Use of Clinical Endpoint Adjudication Committees Finding Increasing Favor with Regulators
Date:3/28/2011

BALA CYNWYD, Pa., March 28, 2011 /PRNewswire/ -- Applied Clinical Intelligence, LLC (ACI), an industry leader in clinical endpoint adjudication committees and independent data monitoring committees (www.icommittees.com), announces the opening of registration for a complimentary breakfast seminar in Cambridge, MA. The 90-minute seminar will focus on aligning independent expert committees with development goals.  This is a unique opportunity to learn practical advice about effective design and management of Clinical Endpoint Committees (CECs) and Endpoint Adjudication Committees (EACs).

"The regulatory pressure for independent adjudication of composite endpoints is escalating, and we want to make sure that those involved in drug, biotech, and device development understand the potential regulatory issues," said Dr. Jonathan Seltzer, MD, MBA, FACC, President and CEO of ACI.  Please join us for this unique learning opportunity.  For your convenience, the seminar is being offered on both April 5th and April 6th in Cambridge, MA from 8:30 a.m. to 10 a.m. ACI will also host seminars in different regions over the next few months.  Registration details for this complimentary seminar are available at http://www.a-ci.com/index.php?id=62.

Topics will include:

  • Practical issues with adjudication of Composite Endpoints and MACE
  • Regulatory strategy for Clinical Endpoint Adjudication
  • Independent Expert Compensation and Sunshine Laws
  • Issues with Image Adjudication presented by Intrinsic Imaging (www.intrinsiccro.com)

Please also visit our iCommittees™ website for more information: www.icommittees.com.

About Applied Clinical Intelligence

ACI provides integrated and highly efficient risk reduction solutions for clinical research.  iCommittees™ is a comprehensive, independent expert committee solution offering management, regulatory-grade biostatistical support, automated processes and documentation expertise for Data Monitoring Committees (DSMBs) and EACs.  Founded in 2001, ACI is headquartered in the Philadelphia area and has deployed its automated solutions to hundreds of trials in over 50 countries.  For more information, please visit www.a-ci.com.

Contact:
Kelly Ryan
484-429-7200


'/>"/>
SOURCE Applied Clinical Intelligence, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... AMSTERDAM , April 20, 2017  AbbVie ... that 99 percent (n=145/146) of chronic hepatitis C ... 4, 5 or 6 and compensated cirrhosis (Child-Pugh ... post-treatment (SVR 12 ) with its investigational, pan-genotypic ... rates were seen following 12 weeks of ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis ... (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the report ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... North American CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication ... 60,000 North American professional caregivers for the prestigious award each year – identifying ...
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in the ... water-related accidents and drownings during the summer. While most of us assume this type ... occur every day. Very few people are taking the time to learn how to ...
Breaking Medicine News(10 mins):